|
117 |
Genematrix acquired official approval by ANVISA for COVID-19 detection kit
|
2020.10.13 |
|
116 |
Genematrix, selected as the “Self-sufficiency project for Essential vaccination” by the government
|
2020.10.08 |
|
115 |
Genematrix acquired approval by KFDAㆍCE for Multiplex detection kit for 9 types of respiratory infection viruses
|
2020.10.06 |
|
114 |
Genematrix acquired export permit for COVID-19 and Influenza, aiming at EUA
|
2020.09.29 |
|
113 |
Genematrix and UNICEF signed a Long-Term Agreement(LTA) for supply of COVID-19 detection kit
|
2020.09.29 |
|
112 |
Genematrix acquired FDA EUA for COVID-19 detection kit
|
2020.09.22 |
|
111 |
Gene Matrix, operating profit of 3.9 billion won in the first half...turned a profit compared to the previous year
|
2020.08.14 |
|
110 |
Genematrix signed a contract to supply COVID-19 detection kit for 500 Million won
|
2020.06.08 |
|
109 |
Genematrix signed a contract to supply COVID-19 detection kit for 500 Million won
|
2020.06.05 |
|
108 |
Genematrix applied for a new technology patent based on T-cell immunotherapy
|
2020.06.02 |
|
107 |
Genematrix acquired EUA for COVID-19 detection kit
|
2020.05.15 |
|
106 |
MSS(Ministry of SMEs and Startups) holds a meeting with companies with R&D achievements in quarantine and zero-contact
|
2020.05.04 |
|
105 |
Genematrix's detection kit for 10 respiratory viruses, approved by KFDA
|
2020.04.29 |
|
104 |
Genematrix signed a 500 million won contract with an Italian local agent
|
2020.04.16 |
|
103 |
Genematrix signed a 400 million won supply contract to export COVID-19 detection kit to Italy
|
2020.04.07 |
ENG